Your browser doesn't support javascript.
loading
Cross-Cancer Genome-Wide Association Study of Endometrial Cancer and Epithelial Ovarian Cancer Identifies Genetic Risk Regions Associated with Risk of Both Cancers.
Glubb, Dylan M; Thompson, Deborah J; Aben, Katja K H; Alsulimani, Ahmad; Amant, Frederic; Annibali, Daniela; Attia, John; Barricarte, Aurelio; Beckmann, Matthias W; Berchuck, Andrew; Bermisheva, Marina; Bernardini, Marcus Q; Bischof, Katharina; Bjorge, Line; Bodelon, Clara; Brand, Alison H; Brenton, James D; Brinton, Louise A; Bruinsma, Fiona; Buchanan, Daniel D; Burghaus, Stefanie; Butzow, Ralf; Cai, Hui; Carney, Michael E; Chanock, Stephen J; Chen, Chu; Chen, Xiao Qing; Chen, Zhihua; Cook, Linda S; Cunningham, Julie M; De Vivo, Immaculata; deFazio, Anna; Doherty, Jennifer A; Dörk, Thilo; du Bois, Andreas; Dunning, Alison M; Dürst, Matthias; Edwards, Todd; Edwards, Robert P; Ekici, Arif B; Ewing, Ailith; Fasching, Peter A; Ferguson, Sarah; Flanagan, James M; Fostira, Florentia; Fountzilas, George; Friedenreich, Christine M; Gao, Bo; Gaudet, Mia M; Gawelko, Jan.
Afiliação
  • Glubb DM; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • Thompson DJ; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Aben KKH; Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Alsulimani A; Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands.
  • Amant F; Division of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York.
  • Annibali D; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University Hospitals KU Leuven, University of Leuven, Leuven, Belgium.
  • Attia J; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University Hospitals KU Leuven, University of Leuven, Leuven, Belgium.
  • Barricarte A; Hunter Medical Research Institute, John Hunter Hospital, Newcastle, New South Wales, Australia.
  • Beckmann MW; Centre for Clinical Epidemiology and Biostatistics, School of Medicine and Public Health, University of Newcastle, Callaghan, New South Wales, Australia.
  • Berchuck A; CIBER of Epidemiology and Public Health (CIBERESP), Madrid, Spain.
  • Bermisheva M; Navarra Public Health Institute, Pamplona, Spain.
  • Bernardini MQ; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.
  • Bischof K; Department of Gynecology and Obstetrics, Comprehensive Cancer Center ER-EMN, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.
  • Bjorge L; Department of Gynecologic Oncology, Duke University Hospital, Durham, North Carolina.
  • Bodelon C; Institute of Biochemistry and Genetics, Ufa Federal Research Centre of the Russian Academy of Sciences, Ufa, Russia.
  • Brand AH; Division of Gynecologic Oncology, University Health Network, Princess Margaret Hospital, Toronto, Ontario, Canada.
  • Brenton JD; Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway.
  • Brinton LA; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Bruinsma F; Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway.
  • Buchanan DD; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Burghaus S; Division of Cancer Epidemiology and Genetics, NCI, Bethesda, Maryland.
  • Butzow R; Department of Gynaecological Oncology, Westmead Hospital, Sydney, New South Wales, Australia.
  • Cai H; University of Sydney, Sydney, New South Wales, Australia.
  • Carney ME; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.
  • Chanock SJ; Division of Cancer Epidemiology and Genetics, NCI, Bethesda, Maryland.
  • Chen C; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia.
  • Chen XQ; Department of Clinical Pathology, The University of Melbourne, Melbourne, Victoria, Australia.
  • Chen Z; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
  • Cook LS; Genomic Medicine and Family Cancer Clinic, Royal Melbourne Hospital, Parkville, Victoria, Australia.
  • Cunningham JM; University of Melbourne Centre for Cancer Research, Victorian Comprehensive Cancer Centre, Parkville, Victoria, Australia.
  • De Vivo I; Department of Gynecology and Obstetrics, Comprehensive Cancer Center ER-EMN, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.
  • deFazio A; Department of Pathology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
  • Doherty JA; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee.
  • Dörk T; John A. Burns School of Medicine, Department of Obstetrics and Gynecology, University of Hawaii, Honolulu, Hawaii.
  • du Bois A; Division of Cancer Epidemiology and Genetics, NCI, NIH, Department of Health and Human Services, Bethesda, Maryland.
  • Dunning AM; Epidemiology Program, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Dürst M; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • Edwards T; Department of Biostatistics, Moffitt Cancer Center, Tampa, Florida.
  • Edwards RP; University of New Mexico Health Sciences Center, University of New Mexico, Albuquerque, New Mexico.
  • Ekici AB; Department of Cancer Epidemiology and Prevention Research, Alberta Health Services, Calgary, Alberta, Canada.
  • Ewing A; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
  • Fasching PA; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Ferguson S; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Flanagan JM; Department of Gynaecological Oncology, Westmead Hospital, Sydney, New South Wales, Australia.
  • Fostira F; Centre for Cancer Research, The Westmead Institute for Medical Research, The University of Sydney, Sydney, New South Wales, Australia.
  • Fountzilas G; Huntsman Cancer Institute, Department of Population Health Sciences, University of Utah, Salt Lake City, Utah.
  • Friedenreich CM; Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
  • Gao B; Department of Gynecology and Gynecologic Oncology, Ev. Kliniken Essen-Mitte (KEM), Essen, Germany.
  • Gaudet MM; Praxis für Humangenetik, Wiesbaden, Germany.
  • Gawelko J; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
Cancer Epidemiol Biomarkers Prev ; 30(1): 217-228, 2021 01.
Article em En | MEDLINE | ID: mdl-33144283
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias do Endométrio Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Female / Humans Idioma: En Revista: Cancer Epidemiol Biomarkers Prev Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias do Endométrio Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Female / Humans Idioma: En Revista: Cancer Epidemiol Biomarkers Prev Ano de publicação: 2021 Tipo de documento: Article